Microbiome transplant for constipation and bloating in scleroderma
Treatments studied
Part of Skin clinical trials.
This study tests a microbiome transplant (friendly bacteria given as an enema or in capsules) to see if it helps with constipation and bloating in people with scleroderma. The goal is to improve digestive symptoms related to your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have scleroderma (systemic sclerosis) confirmed by a doctor.
- You have ongoing constipation or significant bloating.
- You can follow a stable diet for at least 4 weeks before and during the study.
- You are not taking antibiotics currently or in the last month.
- You have not had your colon removed or have a colostomy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to do a fecal transplant (called washed microbiota transplantation) to help people with long-term constipation. It uses a special device to prepare the transplant, and the goal is to see how safe and effective it is.
This trial tests a treatment called washed microbiota transplantation (a procedure that delivers healthy gut bacteria to your colon) for adults with chronic constipation. The goal is to see if it can improve bowel movements without the need for laxatives.
This trial tests whether transplanting stool bacteria (called fecal microbiota transplantation, or FMT) can improve symptoms in people with active ulcerative colitis. You may be able to help test a new approach for restoring gut bacteria, while receiving standard ulcerative colitis care from your doctor.
This study tests whether a special diet can help reduce bloating and stomach discomfort in people with scleroderma (systemic sclerosis). You'll follow a specific meal plan to see if it improves your digestive symptoms.
This study tests whether transplanting healthy gut bacteria (microbiota) combined with prebiotics can help people with long-term constipation that hasn't gotten better with standard treatments. It may offer a new option for those who have tried laxatives and other therapies without relief.
This trial tests whether a fecal (stool) transplant from a healthy donor can help people with both PSC and inflammatory bowel disease. It aims to see if the treatment can improve liver health and reduce inflammation. You must have early to moderate liver scarring and be on stable medications.
Hear when a new Constipation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.